ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections
Infections
Post-Acute COVID-19 Syndrome
Pneumonia
Human Influenza
Virus Diseases
Respiratory Tract Infections

COVID-19 trials near Austin, TX, USA:

Study of a Recombinant Spike COVID-19 Vaccine With Matrix-M in Older Adults and People at Increased Risk of Severe COVID-19

condition that puts them at increased risk for severe outcomes of COVID-19 and who have been previously vaccinated with a COVID...

Enrolling
COVID-19
Biological: Omicron Subvariant-Based SARS-CoV-2 Recombinant Spike Vaccine Adjuvanted With Matrix-M

Phase 4

Sanofi
Sanofi

Austin, Texas, United States and 19 other locations

This early-stage study will look at a new mRNA vaccine that combines defenses against both seasonal flu and COVID-19 in terms of it-...

Enrolling
Influenza, Human+COVID-19
Biological: Licensed COVID-19 Vaccine
Biological: Investigational mRNA Seasonal Flu/COVID-19 Combination (Flu/COVm) Vaccine

Phase 1

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Austin, Texas, United States and 11 other locations

vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...

Active, not recruiting
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: VXA-CoV2-3.3

Phase 2

Vaxart

Austin, Texas, United States and 144 other locations

(SC) routes in healthy adults and adults at higher risk for severe COVID-19. Participants will receive single IV, IM, and SC doses ...

Enrolling
COVID-19 (Prevention)
COVID -19
Biological: MDX2301
Biological: Normal Saline

Phase 1

ModeX Therapeutics

Austin, Texas, United States and 1 other location

the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...

Active, not recruiting
SARS-CoV-2
Biological: mRNA-1283
Biological: mRNA-1273

Phase 4

Moderna
Moderna

Austin, Texas, United States and 149 other locations

This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...

Active, not recruiting
SARS-CoV-2 Infection
Biological: Intramuscular vaccine
Drug: Intramuscular injection

Phase 2, Phase 3

Medicago

Austin, Texas, United States of America and 91 other locations

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting
Early Alzheimer's Disease
Drug: Lecanemab SC
Drug: Placebo

Phase 3

Eisai
Eisai

Austin, Texas, United States of America and 249 other locations

) neo-antigen in subjects with relapsing multiple sclerosis (RMS).COVID-19 sub-study:The purpose of this research sub-study is to e...

Active, not recruiting
Relapsing Multiple Sclerosis
Biological: 23-valent pneumococcal polysaccharide vaccine (23-PPV)
Biological: Tetanus toxoid (TT) containing vaccine (Td, Tdap)

Phase 3

Novartis
Novartis

Round Rock, Texas, United States and 299 other locations

treatment in Study M16-067 with no final endoscopy due to the Covid-19 pandemic or due to the geopolitical conflict in Ukraine and ...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: placebo for risankizumab
Drug: risankizumab

Phase 3

AbbVie
AbbVie

Cedar Park, Texas, United States and 435 other locations

in Study M16-006 or Study M15-991 with no final endoscopy due to the Covid-19 pandemic. Additional objectives are to further invest...

Active, not recruiting
Crohn's Disease
Drug: Placebo for Risankizumab IV
Drug: Risankizumab SC

Phase 3

AbbVie
AbbVie

Cedar Park, Texas, United States and 506 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems